SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?


To: Sycamore who wrote (9842)6/18/1998 4:08:00 PM
From: Colby  Respond to of 23519
 
<<Or perhaps a partnership with a big firm to market MUSE in the USA. The sooner the better.>>

I couldn't agree more. If VVUS were to play this card, I think the stock would jump up to around fifteen in a couple of days for two reasons, especially if it was with a big marketer (like Merck or J&J).
1) The street's big grip with Mngmt. is their inability to market. I think they have done very well producing product. Although their failure to inform the Street of their production shortful wasn't the greatest move,
their decision to cut production was very justified. So, shift this responsibility to another party with a solid reputation and watch out.
2) Having the confidence and the backing of a major player will give a lot of comfort to shareholders, both current and prospective.

Who know what will happen, but I think this is more likely than selling the company. JMHO.

Colby